Scientists probe why common catatonia drug fails for some
NCT ID NCT04530734
Summary
This study aims to understand why a standard drug for catatonia, a severe movement disorder, works for most people but not all. Researchers will measure drug levels in the blood and look at genetic factors in 100 adult patients to see if these can predict who will respond to treatment. The goal is to help doctors identify non-responders early so they can try other treatments sooner.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATATONIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Fontan, CHU lille
RECRUITINGLille, 59037, France
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.